1. Home
  2. TXG vs KVYO Comparison

TXG vs KVYO Comparison

Compare TXG & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$34.68

Market Cap

3.6B

Sector

Industrials

ML Signal

HOLD

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$13.19

Market Cap

4.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
KVYO
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.3B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
TXG
KVYO
Price
$34.68
$13.19
Analyst Decision
Hold
Strong Buy
Analyst Count
15
21
Target Price
$20.25
$34.48
AVG Volume (30 Days)
3.2M
5.4M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
35.29
EPS
N/A
0.03
Revenue
$245,893,000.00
$1,234,019,000.00
Revenue This Year
N/A
$24.47
Revenue Next Year
$7.33
$19.66
P/E Ratio
N/A
$438.83
Revenue Growth
68.06
31.63
52 Week Low
$11.17
$13.10
52 Week High
$35.65
$36.76

Technical Indicators

Market Signals
Indicator
TXG
KVYO
Relative Strength Index (RSI) 70.67 34.34
Support Level $16.11 N/A
Resistance Level $35.65 $21.74
Average True Range (ATR) 2.41 0.92
MACD 0.23 -0.13
Stochastic Oscillator 91.84 0.00

Price Performance

Historical Comparison
TXG
KVYO

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

Share on Social Networks: